Clinical Trials Logo

High Risk Pregnancy clinical trials

View clinical trials related to High Risk Pregnancy.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04110444 Withdrawn - High Risk Pregnancy Clinical Trials

Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy

Start date: January 2017
Phase:
Study type: Observational

Anticoagulant therapy is indicated during pregnancy for the prevention and treatment of venous thromboembolism, systemic embolism in patients with mechanical heart valves and, in combination with aspirin, for the prevention of recurrent pregnancy loss in women with antiphospholipid antibodies Sildenafil citrate increases uterine blood flow and potentiates estrogen-induced vasodilatation. Intravaginal administration of Sildenafil in the success of in vitro fertilization describes no deleterious effects on mother and fetus